INTRODUCTION
resistance rate was recently reported as almost 100% in China [9] . The high resistance rate of GAS to macrolides in some countries, including Korea [9] [10] [11] , is a concern when selecting the best treatment regimen for GAS pharyngitis.
Typing of the emm gene, which encodes the M protein, is more useful for epidemiologic studies of GAS than direct typing of M, which requires multiple kinds of anti-M sera. As more and more clinical microbiology laboratories incorporate PCR and DNA sequencing, the performance of emm genotyping has become more available [12] . Genotyping of emm has become a standard method for the study of GAS epidemiology, thereby replacing the ambiguous reactions of T typing, time-consuming M typing, or the limited resources of opacity factor (OF) typing, which are conventional serological typing methods for GAS. The distribution of emm genotypes during a defined period can be used to understand the dynamic changes in GAS strains in the region. Several reports have been published on the correlation between emm genotypes and antibiotic resistance, but the distributions of antibiotic-resistant emm genotypes vary geographically [13, 14] . In general, antibiotic resistance is closely associated with the consumption of drugs. As it was too difficult to acquire drug consumption data, we used the production cost data from the pharmaceutical companies instead.
The aim of this study was to investigate the epidemiology of GAS isolated from patients with acute pharyngitis in 2009 in Jinju, Korea, using emm genotypes, macrolide resistance phenotypes, and resistance determinants. We also compared our results with data from 2002 to identify any change in the epidemiology of GAS causing acute pharyngitis in the same geographic region.
MATERIALS AND METHODS

Sample collection and isolation of bacteria
Throat swab specimens were taken from 499 children 
ERY resistance phenotypes
The phenotypes of ERY resistance were evaluated using the previously described double disk synergy test [15] . 
ERY resistance genes
All ERY-resistant isolates were screened for causative resistance determinants. The erm(B), erm(A), and mef(A) genes were detected using PCR amplification with specific primers [11] . The PCR products were analyzed using 1.5% agarose gel electrophoresis in TBE (Tris/borate/EDTA) buffer (pH 8.0).
emm genotyping
The AccuPower DNA Extraction Kit (Bioneer, Chungwon, Korea) was used to extract bacterial DNA from the colonies on agar plates. The PCR was carried out using the AccuPower PCR PreMix Kit (Bioneer) and known emm primers in a thermal cycler (GeneAmp 9700, Perkin-Elmer Co., Foster City, CA, USA). Once the amplification products were confirmed by gel electrophoresis, they were purified with the AccuPrep PCR Purification Kit (Bioneer) and sequenced using the Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystem, Foster City, CA, USA) and the BLAST program (http://ncbi. nlm.nih.gov) provided by the National Center for Biotechnology Information (NCBI).
Macrolide production
Data on the annual macrolide production were col- 
Statistical analysis
The isolation rates of GAS, antibiotic resistance rates, and the distribution of ERY-resistant phenotypes and emm genotypes between 2002 and 2009 were compared using Chi-square tests. A P value of <0.05 indicated statistical significance.
RESULTS
Macrolide-resistant phenotypes and genotypes
Out of 174 GAS isolates, the resistance rates to ERY, CLI, and tetracycline were 4.6%, 2.9%, and 2.3%, respectively. Among 8 ERY-resistant strains, 62.5% had the cMLSB phenotype and 37.5% had the M phenotype. No cases of iMLSB were observed (Table 1 ). All 5 cMLSB strains harbored the erm(B) gene and were typed as emm28, while 3 strains with the M phenotype were positive for the mef(A) gene and were identified as emm28 (2 strains) and emm89 (1 strain). None of the ERY-resistant strains had more than 1 resistance gene.
Distribution of emm genotypes
The most frequent genotype was emm4, accounting for 28.2% followed by emm89 (20.1%) and emm6 (12.1%) ( Table 2 ). Strains with emm28 showed a high ERY resistance rate (58.3%), while most of the other emm types were ERY-susceptible (Fig. 1) .
Comparison with data from 2002
We conducted antimicrobial susceptibility testing and emm genotyping of 125 GAS isolates from patients with acute pharyngitis in 2002 in the same region. The resistance rates to ERY, CLI, and tetracycline were as high as 44.8%, 19.2%, and 23.2%, respectively, in 2002 [16] .
The most common genotype was emm12, accounting for Koh 
Changes in macrolide production
The analysis of the data on the annual macrolide pro- (Table 3) . Although the proportion of each macrolide differed every year, a decrease in the erythromycin and midecamycin production as well as a markedly increased production of clarithromycin and roxithromycin were noted during the study period.
DISCUSSION
The increase in macrolide resistance among GAS is a concern, because macrolides are the common regimen for the treatment of pharyngitis caused by GAS as well as other pathogens, such as chlamydia and mycoplasma.
In the present study, ERY resistance was observed only in 8 strains among 174 isolates (4.6%), which represents a significant decrease compared to the resistance rate in 2002 (44.8%) [16] . The ERY resistance rate of GAS isolated from patients with acute pharyngitis was reported to be 20.5% using data obtained over a 6-yr period (1998-2003) from provincial health institutes and clinical centers in our country [17] . Another group reported an ERY resistance rate of 23%, which was based on data collected over a 5-yr period (1997) (1998) (1999) (2000) (2001) (2002) (2003) in Seoul and Masan [10] . Changes in the prescription pattern of antibiotics or macrolide consumption could theoretically have an impact on the resistance rates to ERY for GAS [18, 19] , but these parameters are difficult to estimate without the respective data. If we assume that the production of drugs is closely correlated with consumption, we could utilize the production data to estimate their consumption. Recently, a remarkable increase in the production of new macrolides has been noted (Table 3) , which indicated that the use of macrolides is not restricted. It is also important to know whether the currently observed decrease in ERY resistance rate is restricted to our region or is a nationwide phenomenon.
In general, high ERY resistance rates are associated with the MLSB phenotype, whereas the M phenotype is found more frequently in countries with lower resistance rates [20] . A close association between the emm genotype and antibiotic resistance has been reported [5, 13] . We observed an ERY resistance rate of 4.6%, suggesting that almost all isolates were susceptible and that the ERY-resistant isolates belonged to a few limited emm types, such as emm28 and emm89. The strains with emm28 showed a high ERY resistance rate (58.3%), suggesting that strains with this emm genotype are highly resistant. All erm(B)-positive ERY-resistant GAS isolates had an emm28 genotype, which accounts for 50% and 70% of erm(B)-positive ERY-resistant GAS isolates in North America [21] and France [6] , respectively. In our previous study (2002), the ERY resistance rate of emm12 strains was 63%, and most of them had the cMLSB phenotype, whereas emm18 and emm75 strains had the M phenotype. We did not detect emm89 isolates, whereas emm2, 3, 12, 18, 22, and 75 were rather common [16] . Among them, emm22 and We recently reported decreases in ERY and CLI resistance rates of GAS in normal school children in our region [15] . In these children, the ERY and CLI resistance rates decreased from 51.0% and 33.7% in 2002 [22] In conclusion, the ERY resistance rate of GAS isolated from children with acute pharyngitis in 2009 decreased dramatically compared to that of 2002. This significant decrease in ERY resistance over a 7-yr span could be associated with changes in the distribution of the emm genotypes rather than restriction of antibiotic usage.
